Cargando…

Current Status in the Therapy of Liver Diseases

Hepatic diseases, like viral hepatitis, autoimmune hepatitis, hereditary hemochromatosis, non-alcoholic fatty liver disease (NAFLD) and Wilson’s disease, play an important role in the development of liver cirrhosis and, hence, hepatocellular carcinoma. In this review, the current treatment options a...

Descripción completa

Detalles Bibliográficos
Autores principales:	Uhl, Philipp, Fricker, Gert, Haberkorn, Uwe, Mier, Walter
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Molecular Diversity Preservation International (MDPI) 2014
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4057686/ https://www.ncbi.nlm.nih.gov/pubmed/24786290 http://dx.doi.org/10.3390/ijms15057500

Ejemplares similares

Synthesis of Peptide Radiopharmaceuticals for the Therapy and Diagnosis of Tumor Diseases
por: Jamous, Mazen, et al.
Publicado: (2013)

Cancer Stratification by Molecular Imaging
por: Weber, Justus, et al.
Publicado: (2015)

Miniproteins as Phage Display-Scaffolds for Clinical Applications
por: Zoller, Frederic, et al.
Publicado: (2011)

DNA Libraries for the Construction of Phage Libraries: Statistical and Structural Requirements and Synthetic Methods
por: Lindner, Thomas, et al.
Publicado: (2011)

Radiolabeling Strategies for Tumor-Targeting Proteinaceous Drugs
por: Sugiura, Grant, et al.
Publicado: (2014)

Is nano too big?
por: Mier, Walter, et al.
Publicado: (2013)

Fatty Acid Conjugation Leads to Length-Dependent Antimicrobial Activity of a Synthetic Antibacterial Peptide (Pep19-4LF)
por: Storck, Philip, et al.
Publicado: (2020)

Vancomycin-Lipopeptide Conjugates with High Antimicrobial Activity on Vancomycin-Resistant Enterococci
por: Mühlberg, Eric, et al.
Publicado: (2020)

Current State of Radiolabeled Heterobivalent Peptidic Ligands in Tumor Imaging and Therapy
por: Judmann, Benedikt, et al.
Publicado: (2020)

Chelation therapy in liver diseases of childhood: Current status and response
por: Seetharaman, Jayendra, et al.
Publicado: (2021)

Vancomycin Resistance Is Overcome by Conjugation of Polycationic Peptides
por: Umstätter, Florian, et al.
Publicado: (2020)

Solid-Phase Synthesis of the Lipopeptide Myr-HBVpreS/2-78, a Hepatitis B Virus Entry Inhibitor
por: Schieck, Alexa, et al.
Publicado: (2010)

Impact of Linker Modification and PEGylation of Vancomycin Conjugates on Structure-Activity Relationships and Pharmacokinetics
por: Umstätter, Florian, et al.
Publicado: (2022)

The Role of Solute Carrier Transporters in Efficient Anticancer Drug Delivery and Therapy
por: Puris, Elena, et al.
Publicado: (2023)

Current status of imaging in nonalcoholic fatty liver disease
por: Li, Qian, et al.
Publicado: (2018)

Gene Therapy for Liver Cancers: Current Status from Basic to Clinics
por: Kamimura, Kenya, et al.
Publicado: (2019)

[(153)Sm]Samarium-labeled FAPI-46 radioligand therapy in a patient with lung metastases of a sarcoma
por: Kratochwil, Clemens, et al.
Publicado: (2021)

PSMA ligands for diagnosis and therapy of prostate cancer
por: Haberkorn, Uwe
Publicado: (2014)

Gene Therapy for Pancreatic Diseases: Current Status
por: Kamimura, Kenya, et al.
Publicado: (2018)

Repeated PSMA-targeting radioligand therapy of metastatic prostate cancer with (131)I-MIP-1095
por: Afshar-Oromieh, Ali, et al.
Publicado: (2017)

The Intestinal Microbiota in the Development of Chronic Liver Disease: Current Status
por: Stojic, Josip, et al.
Publicado: (2023)

The current status of gene therapy for Parkinson's disease
por: Muramatsu, Shin-ichi
Publicado: (2010)

Development and dosimetry of (203)Pb/(212)Pb-labelled PSMA ligands: bringing “the lead” into PSMA-targeted alpha therapy?
por: dos Santos, José Carlos, et al.
Publicado: (2019)

Current Status of Herbal Medicines in Chronic Liver Disease Therapy: The Biological Effects, Molecular Targets and Future Prospects
por: Hong, Ming, et al.
Publicado: (2015)

A dimerized urea-based inhibitor of the prostate-specific membrane antigen for (68)Ga-PET imaging of prostate cancer
por: Schäfer, Martin, et al.
Publicado: (2012)

Peptide-Based Targeting of the Platelet-Derived Growth Factor Receptor Beta
por: Askoxylakis, Vasileios, et al.
Publicado: (2012)

Current status of disparity in liver disease
por: Sempokuya, Tomoki, et al.
Publicado: (2022)

Radiation dosimetry and first therapy results with a (124)I/(131)I-labeled small molecule (MIP-1095) targeting PSMA for prostate cancer therapy
por: Zechmann, Christian M., et al.
Publicado: (2014)

Current Status of ABO-incompatible Liver Transplantation
por: Egawa, Hiroto, et al.
Publicado: (2022)

Targeting of activated fibroblasts for imaging and therapy
por: Lindner, Thomas, et al.
Publicado: (2019)

Current and future therapies for inherited cholestatic liver diseases
por: van der Woerd, Wendy L, et al.
Publicado: (2017)

Optimization of a Novel Peptide Ligand Targeting Human Carbonic Anhydrase IX
por: Rana, Shoaib, et al.
Publicado: (2012)

Gene Therapy for Mitochondrial Diseases: Current Status and Future Perspective
por: Di Donfrancesco, Alessia, et al.
Publicado: (2022)

Current status, problems, and perspectives of non-alcoholic fatty liver disease research
por: Tanaka, Naoki, et al.
Publicado: (2019)

Current Status of Dialysis Therapy in Korea
por: Jin, Dong Chan
Publicado: (2011)

Current status of laparoscopic liver resection for hepatocellular carcinoma
por: Guro, Hanisah, et al.
Publicado: (2016)

Current status of surgical treatment of colorectal liver metastases
por: Xu, Feng, et al.
Publicado: (2018)

(18)F-Labelled PSMA-1007 shows similarity in structure, biodistribution and tumour uptake to the theragnostic compound PSMA-617
por: Giesel, Frederik L., et al.
Publicado: (2016)

Current Status in Testing for Nonalcoholic Fatty Liver Disease (NAFLD) and Nonalcoholic Steatohepatitis (NASH)
por: Drescher, Hannah K., et al.
Publicado: (2019)

Gut microbiome and metabolic-associated fatty liver disease: Current status and potential applications
por: Guo, Gong-Jing, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_kr1r9qeus6klhdk75al1jvauck